Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-014602
Filing Date
2025-05-27
Accepted
2025-05-27 16:10:06
Documents
1
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 form4-05272025_040501.html 4  
1 form4-05272025_040501.xml 4 3758
  Complete submission text file 0001415889-25-014602.txt   5185
Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Issuer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O OVASCIENCE, INC. 9 FOURTH AVENUE WALTHAM MA 02451
Business Address
Mohideen Pharis (Reporting) CIK: 0001760395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36697 | Film No.: 25988329